Complete functional rescue of the ABCA1−/− mouse by human BAC transgenesis Published, JLR Papers in Press, March 16, 2005. DOI 10.1194/jlr.M400506-JLR200

Humanized mouse models are useful tools to explore the functional and regulatory differences between human and murine orthologous genes. We have combined a bioinformatics approach and an in vivo approach to assess the functional and regulatory differences between the human and mouse ABCA1 genes. Computational analysis identified significant differences in potential regulatory sites between the human and mouse genes. The effect of these differences was assessed in vivo, using a bacterial artificial chromosome transgenic humanized ABCA1 mouse model that expresses the human gene in the absence of mouse ABCA1. Humanized mice expressed human ABCA1 protein at levels similar to wild-type mice and fully compensated for cholesterol efflux activity and lipid levels seen in ABCA1-deficient mice. Liver X receptor agonist administration resulted in significant increases in HDL values associated with parallel increases in the hepatic ABCA1 protein and mRNA levels in the humanized ABCA1 mice, as seen in the wild-type animals. Our studies indicate that despite differences in potential regulatory regions, the human ABCA1 gene is able to functionally fully compensate for the mouse gene. Our humanized ABCA1 mice can serve as a useful model system for functional analysis of the human ABCA1 gene in vivo and can be used for the generation of potential new therapeutics that target HDL metabolism.

[1]  M. Hayden,et al.  Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. , 2005, The Journal of clinical investigation.

[2]  A. Sandelin,et al.  Prediction of nuclear hormone receptor response elements. , 2005, Molecular endocrinology.

[3]  Liang Chen,et al.  Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor Published, JLR Papers in Press, August 1, 2004. DOI 10.1194/jlr.M400257-JLR200 , 2004, Journal of Lipid Research.

[4]  I. Yanai,et al.  Incongruent expression profiles between human and mouse orthologous genes suggest widespread neutral evolution of transcription control. , 2004, Omics : a journal of integrative biology.

[5]  Wyeth W. Wasserman,et al.  ConSite: web-based prediction of regulatory elements using cross-species comparison , 2004, Nucleic Acids Res..

[6]  J. Ward,et al.  Diminished Hepatocellular Proliferation in Mice Humanized for the Nuclear Receptor Peroxisome Proliferator-Activated Receptor α , 2004, Cancer Research.

[7]  Michel Koenig,et al.  Human BAC-mediated rescue of the Friedreich ataxia knockout mutation in transgenic mice , 2004, Mammalian Genome.

[8]  A. Sandelin,et al.  Applied bioinformatics for the identification of regulatory elements , 2004, Nature Reviews Genetics.

[9]  Francesca Chiaromonte,et al.  Regulatory potential scores from genome-wide three-way alignments of human, mouse, and rat. , 2004, Genome research.

[10]  A. Tall,et al.  Cholesteryl ester transfer protein modulates the effect of liver X receptor agonists on cholesterol transport and excretion in the mouse Published, JLR Papers in Press, December 16, 2003. DOI 10.1194/jlr.M300432-JLR200 , 2004, Journal of Lipid Research.

[11]  M. Hayden,et al.  Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1 Published, JLR Papers in Press, May 1, 2003. DOI 10.1194/jlr.M300110-JLR200 , 2003, Journal of Lipid Research.

[12]  H. Brewer,et al.  Study of ABCA1 function in transgenic mice. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[13]  A. Sandelin,et al.  Identification of conserved regulatory elements by comparative genome analysis , 2003, Journal of biology.

[14]  C. Tohyama,et al.  Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Rader,et al.  Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[16]  H. Brewer,et al.  Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations Published, JLR Papers in Press, November 4, 2002. DOI 10.1194/jlr.M200414-JLR200 , 2003, Journal of Lipid Research.

[17]  S. Goodart,et al.  Mice Expressing the Human CYP7A1 Gene in the Mouse CYP7A1 Knock-out Background Lack Induction of CYP7A1 Expression by Cholesterol Feeding and Have Increased Hypercholesterolemia When Fed a High Fat Diet* , 2002, The Journal of Biological Chemistry.

[18]  Folkert Kuipers,et al.  Stimulation of Lipogenesis by Pharmacological Activation of the Liver X Receptor Leads to Production of Large, Triglyceride-rich Very Low Density Lipoprotein Particles* , 2002, The Journal of Biological Chemistry.

[19]  Sridhar Hannenhalli,et al.  Identification of transcription factor binding sites in the human genome sequence , 2002, Mammalian Genome.

[20]  B. McManus,et al.  Increased ABCA1 activity protects against atherosclerosis. , 2002, The Journal of clinical investigation.

[21]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[22]  W. Fung-Leung,et al.  Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Snaith,et al.  Transgenic systems in drug discovery: from target identification to humanized mice. , 2002, Drug discovery today.

[24]  O. Francone,et al.  Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[25]  J. Oram,et al.  Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1. , 2002, Trends in molecular medicine.

[26]  B. McManus,et al.  ABCA1 mRNA and Protein Distribution Patterns Predict Multiple Different Roles and Levels of Regulation , 2002, Laboratory Investigation.

[27]  R. F. Hoyt,et al.  The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  O. Francone,et al.  Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. , 2001, The Journal of clinical investigation.

[29]  M. Hayden,et al.  Human ABCA1 BAC Transgenic Mice Show Increased High Density Lipoprotein Cholesterol and ApoAI-dependent Efflux Stimulated by an Internal Promoter Containing Liver X Receptor Response Elements in Intron 1* , 2001, The Journal of Biological Chemistry.

[30]  H. Brewer,et al.  ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. , 2001, The Journal of clinical investigation.

[31]  A. Tall,et al.  ATP-binding Cassette Transporter A1 (ABCA1) Functions as a Cholesterol Efflux Regulatory Protein* , 2001, The Journal of Biological Chemistry.

[32]  J. Cheng,et al.  Regulation and Activity of the Human ABCA1 Gene in Transgenic Mice* , 2001, The Journal of Biological Chemistry.

[33]  J. Cheng,et al.  Human and mouse ABCA1 comparative sequencing and transgenesis studies revealing novel regulatory sequences. , 2001, Genomics.

[34]  T. Langmann,et al.  Structure, function and regulation of the ABC1 gene product , 2001, Current opinion in lipidology.

[35]  M. Hayden,et al.  Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. , 2000, The Journal of clinical investigation.

[36]  C. Lawrence,et al.  Human-mouse genome comparisons to locate regulatory sites , 2000, Nature Genetics.

[37]  A. Tall,et al.  Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. , 2000, The Journal of biological chemistry.

[38]  J. Cheng,et al.  Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  C. Gabel,et al.  High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Hayden,et al.  Cholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiency , 2000, Current opinion in lipidology.

[41]  A. Attie,et al.  The role of the LDL receptor in apolipoprotein B secretion. , 2000, The Journal of clinical investigation.

[42]  A. Wagner,et al.  Decoupled evolution of coding region and mRNA expression patterns after gene duplication: implications for the neutralist-selectionist debate. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[43]  T. Langmann,et al.  The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease , 1999, Nature Genetics.

[44]  J. Piette,et al.  Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 , 1999, Nature Genetics.

[45]  C. Sensen,et al.  Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.

[46]  T. Langmann,et al.  Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. , 1999, Biochemical and biophysical research communications.

[47]  A Rubartelli,et al.  Interleukin-1beta secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1. , 1997, Blood.

[48]  D. Mangelsdorf,et al.  Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR. , 1997, Genes & development.

[49]  M. Luciani,et al.  The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death. , 1996, The EMBO journal.

[50]  K. Umesono,et al.  LXR, a nuclear receptor that defines a distinct retinoid response pathway. , 1995, Genes & development.

[51]  C. Fielding,et al.  Molecular physiology of reverse cholesterol transport. , 1995, Journal of lipid research.

[52]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[53]  P. Linsel-Nitschke,et al.  A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. , 2003, The Journal of clinical investigation.

[54]  C. Carlberg,et al.  Differential nuclear receptor signalling from DR4‐type response elements , 2002, Journal of cellular biochemistry.